BOB体育

Skip to main content
  • Tinks Trial

    The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with鈥�

    Investigator
    John A Ligon
    Ages
    2 Years - 40 Years
    Sexes
    All